[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"wearable-devices\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:wearable-devices":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,6,0,[8,44,72,98,128,167],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":4},"100625558","physiological-benefits-from-the-removal-of-tracheostomy-tubes-obtained-via-wearable-devices-100625558",false,"NCT07424196","Physiological Benefits From the Removal of Tracheostomy Tubes (Obtained Via Wearable Devices)","Collect Physiological Data of Patients Before and After Tracheostomy Tube Removal Using Wearable Devices to Quantify Physiological Benefits of Decannulation","RVTR1","Inclusion Criteria:\n\n* 18 years≤Age≤90 years, non-mechanically ventilated patients.\n* Tracheotomy completed, ≥48 hours since cannula placement (postoperative early edema has stabilized).\n* Patient or legal representative has provided informed consent.\n* Following our department's 2018 decannulation procedure, patients who successfully completed decannulation\n\nExclusion Criteria:\n\n* Patients with abnormal skin conditions preventing continuous wearing of monitoring devices;\n* Interruption of physiological monitoring data;\n* Poor quality of physiological monitoring data;\n* Recent (≤48 hours) major neck\u002Fupper airway surgery requiring avoidance of upper airway airflow impact.\n* Severe consciousness disorder\u002Fdelirium (RASS ≤ -3 or ≥ +2), extreme anxiety\u002Finability to cooperate.\n* Total laryngectomy or laryngo-tracheal separation.\n* Age \\\u003C18 years, Age \\> 90years.\n* Malignant tumor with an expected survival time ≤ 6 months.\n* Patients or legal representatives unable to obtain informed consent.\n* Known contraindications for tracheotomy decannulation.\n* Unable to comply with the use of wearable devices","ALL","18 Years","90 Years",{"count":21,"type":22},60,"ESTIMATED","OBSERVATIONAL","The population included in this study consists of tracheostomy patients admitted to the pulmonary department of Beijing Rehabilitation Hospital, undergoing decannulation rehabilitation treatment. After the patient is admitted, the research team evaluates whether they are suitable to enter the decannulation process. For enrolled patients, a 24-hour wearable device is worn upon admission to record physiological parameters.\n\nPatients, following clinical and rehabilitation treatment, can start using a \"speaking valve\" as soon as their condition permits. Within the first 24 hours prior to the initial use of the speaking valve, wearable devices may be utilized a second time to gather data.\n\nPatients successfully completed the decannulation process, tolerating the speaking valve for 4 hours (PEF\u002FPCF ≥ 100liters\u002Fmin).The wearable device was utilized to gather 24 hours physiological parameters for the third time within the 24 hours leading up to decannulation.\n\nPatients who underwent successful decannulation had physiological parameters collected for the forth time using wearable devices within 24 hours prior to discharge.\n\nThis study preliminarily compares the differences in physiological parameters at four time points (within 24 hours of admission, within 24 hours prior to using a speaking valve, within 24 hours prior to decannulation and within 24 hours before discharge), predicts the physiological benefits of decannulation for patients, and advocates for the concept of \"early decannulation.\" Decannulation criteria: If the patient can tolerate wearing the speaking valve continuously for 4 hours (gradually increasing the duration: 30 minutes, 1 hour, 2 hours, 4 hours), and if PEF\u002FPCF ≥ 100 liters\u002Fmin, planned removal of the tracheostomy tube can be considered.\n\nCriteria for successful decannulation: Patients who successfully completed the decannulation process and had their tubes removed, with no reinsertion of the tracheostomy tube or endotracheal intubation within 48 hours after decannulation.",[26,27,28],"Physiological Parameters","Wearable Devices","Tracheostomy Decannulation",[30,26,27,31],"speaking valve","Tracheostomy decannulation","NOT_YET_RECRUITING","2026-05-30",{"date":35,"type":36},"2026-06-03","ACTUAL",{"date":38,"type":22},"2026-06-01",{"date":40,"type":22},"2027-03-30",{"name":42,"class":43},"Bin Zhang","OTHER",{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":51,"targetDuration":4,"studyType":53,"phases":54,"briefSummary":56,"conditions":57,"keywords":60,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":71},"100639533","predicting-the-clinical-advantages-of-speaking-valves-through-wearable-devices-100639533","NCT07587762","Predicting the Clinical Advantages of Speaking Valves Through Wearable Devices","Predicting the Clinical Advantages of Speaking Valves Through Wearable Devices:A Prospective Cohort Study","Inclusion Criteria:\n\n* 90 years≥Age≥18 years;\n* Tracheotomy post-operation\\>48 hours；\n* Weaned off mechanical ventilation;\n* Clinically stable condition;\n* Tolerable for cuff deflation;\n* Able to tolerate wearing a speaking valve continuously for 30 minutes;\n* Signed informed consent.\n\nExclusion Criteria:\n\n* Patients with abnormal skin conditions preventing continuous wearing of monitoring devices;\n* Inability to tolerate wearing a speaking valve continuously for 30 minutes;\n* Interruption of physiological monitoring data;\n* Poor quality of physiological monitoring data;\n* Recently underwent neck\u002Fupper airway surgery (≤48 hours, to avoid airflow impact on the upper airway);\n* Severe consciousness disturbance\u002Fdelirium (RASS score≤-3 or ≥ +2), extreme anxiety\u002Funcooperativeness;\n* Total laryngectomy or laryngotracheal separation;\n* Age \\\u003C18 years or \\>90 years;\n* Malignant tumor with an expected survival time ≤6 months;\n* The patient or legal representative is unable to sign the informed consent form.",{"count":52,"type":22},120,"INTERVENTIONAL",[55],"NA","The population included in this study consists of tracheostomy patients admitted to the pulmonary department of Beijing Rehabilitation Hospital, undergoing decannulation rehabilitation treatment. Once patient conditions stabilized, they were all transitioned to the decannulation process established by our department in 2018, which utilizes a speaking valve instead of capping.The initial duration for the patient to wear the speaking valve is 30 minutes.The monitoring period for wearable devices is from 1 hour before the initial use of the speaking valve to 1 hour after its removal.Monitored for a total of 2 hours and 30 minutes.Explore the clinical benefits of the speaking valve by comparing the changes in patients' physiological parameters and clinical index metrics before and after using the speaking valve.\n\nCriteria for the successful use of the speaking valve for 30 minutes:\n\n1. Breathing is steady at rest: no apparent dyspnea, chest tightness, or orthopnea, etc.\n2. Heart rate, blood pressure, and SpO₂ are all stable overall.SpO₂ reduction from baseline \\\u003C 5%.\n3. No frequent need for emergency sputum suction or indications of sputum blockage while wearing it.",[58,27,59],"Physiological Parameter","Tracheostomy",[30,27,61,58],"tracheostomy","RECRUITING","2026-05-11",{"date":65,"type":36},"2026-05-14",{"date":67,"type":36},"2026-04-16",{"date":69,"type":22},"2026-12-31",{"name":42,"class":43},1,{"id":73,"slug":74,"hasResults":11,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":4,"eligibilityCriteria":78,"healthyVolunteers":79,"sex":17,"minAge":80,"maxAge":4,"enrollmentInfo":81,"targetDuration":4,"studyType":53,"phases":83,"briefSummary":84,"conditions":85,"keywords":4,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":96,"locationsCount":71},"100627619","effects-of-hip-assist-exoskeleton-torque-on-gait-parameters-100627619","NCT07450989","Effects of Hip-Assist Exoskeleton Torque on Gait Parameters","Effects of Assistive Hip Exoskeleton Torque on Spatiotemporal, Kinematic, Electromyographic, and Plantar Pressure Parameters During Walking in Healthy Adults","Inclusion Criteria:\n\n1. Healthy adults aged 19 years or older without gait impairment.\n2. Body weight between 50kg and 100kg.\n3. No history of hip surgery.\n4. Capable of wearing a hip-assist exoskeleton.\n5. Voluntarily signed the informed consent form.\n\nExclusion Criteria:\n\n1. Skin or musculoskeletal issues that prevent wearing the exoskeleton.\n2. Inability to walk independently while wearing the exoskeleton.\n3. Other conditions deemed inappropriate by the investigator.",true,"19 Years",{"count":82,"type":22},15,[55],"This study aims to evaluate the impact of assistive torque from a hip-assist exoskeleton on gait patterns in healthy adults. The investigators will analyze how different torque settings affect spatiotemporal parameters, joint kinematics, muscle activity (EMG), and foot pressure during walking.",[86,87,27,88,89],"Healthy Volunteers","Robotic Exoskeleton","Assistive Devices","Biomechanics","2026-03-03",{"date":92,"type":36},"2026-03-05",{"date":94,"type":22},"2026-03",{"date":94,"type":22},{"name":97,"class":43},"Yonsei University",{"id":99,"slug":100,"hasResults":11,"nctId":101,"briefTitle":102,"officialTitle":103,"acronym":4,"eligibilityCriteria":104,"healthyVolunteers":79,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":105,"targetDuration":4,"studyType":53,"phases":107,"briefSummary":108,"conditions":109,"keywords":114,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":120,"lastUpdatePostDateStruct":121,"startDateStruct":123,"completionDateStruct":125,"leadSponsor":126,"locationsCount":71},"100612156","feasibility-of-wearables-in-dementia-care-in-rural-taiwan-100612156","NCT07249918","Feasibility of Wearables in Dementia Care in Rural Taiwan","Facilitating the Measurement and Treatment of the Behavioral Symptoms of Dementia (BPSD) and Understanding Caregiver Burden Using Wearable Devices in Rural Taiwan - A Dyadic Feasibility Pilot Study","Inclusion Criteria:\n\n* For participants with dementia:\n\n  1. Clinical diagnosis of probable Alzheimer's disease (AD) or mild cognitive impairment (MCI) due to AD, based on established diagnostic criteria.\n  2. Presence of at least one prominent behavioral or psychological symptom of dementia (BPSD), including depression, agitation, apathy, or nighttime sleep disturbance.\n  3. Prominent is defined as:\n\n     NPI single-item score ≥ 4 (severity × frequency), or NPI-Q severity score ≥ 2, or PSQI total score ≥ 5 (if sleep disturbance is the main symptom).\n  4. Stable living arrangement or care environment for at least two weeks before enrollment.\n  5. If receiving any pharmacological or non-pharmacological treatments for BPSD, the dosage and frequency must have remained stable for at least two weeks prior to study participation.\n  6. Able and willing to provide informed consent; for those lacking decision-making capacity, consent must be obtained from a legally authorized representative.\n* For primary caregivers:\n\n  1. Adult primary caregiver of the enrolled participant.\n  2. If receiving treatment for caregiver stress, the dosage and frequency must have been stable for at least two weeks before enrollment.\n  3. Willing and able to provide informed consent.\n\nExclusion Criteria:\n\n* Any medical condition that may increase risk during participation, including:\n\n  1. Retinal disease, active use of photosensitizing medications, recent ocular surgery (within 4 weeks), or photosensitivity disorders (e.g., epilepsy).\n  2. Unstable physical or mental condition deemed unsuitable by investigators, such as acute delirium or active respiratory infection (including COVID-19)",{"count":106,"type":22},20,[55],"Taiwan is becoming a super-aged society, and more older adults are living with Alzheimer's disease. Many people with Alzheimer's experience behavioral and psychological symptoms, such as agitation, sleep problems, or mood changes. These symptoms often lower their quality of life and increase stress for their family caregivers.\n\nThis study will test two wearable devices in people with Alzheimer's and their caregivers. One device, called Geneactiv, is a wristwatch that tracks daily activity and sleep. The other device, called Re-Timer, is a light therapy eyewear that may help improve sleep and mood. Researchers will look at how easy the devices are to use, whether participants are willing to wear them for several weeks, and whether the light therapy helps reduce sleep problems or caregiver stress.\n\nThe study will also compare information from questionnaires with information collected by the devices. The results may help researchers design future studies using wearable tools to better support people living with dementia and their caregivers.",[110,111,27,112,113],"Alzheimer's Dementia","Neuropsychiatric Symptoms Related to Neurodegenerative Disease","Caregiver Burden of People With Dementia","Circadian Rhythm",[115,116,117,118,119],"Wearable device","behavioural and psychological symptoms of dementia (BPSD)","Sleep","Alzheimer's dementia","Caregiver Burden","2026-02-09",{"date":122,"type":36},"2026-02-11",{"date":124,"type":36},"2025-11-18",{"date":69,"type":22},{"name":127,"class":43},"China Medical University Hospital",{"id":129,"slug":130,"hasResults":11,"nctId":131,"briefTitle":132,"officialTitle":133,"acronym":4,"eligibilityCriteria":134,"healthyVolunteers":11,"sex":17,"minAge":135,"maxAge":4,"enrollmentInfo":136,"targetDuration":137,"studyType":23,"phases":4,"briefSummary":138,"conditions":139,"keywords":149,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":158,"lastUpdatePostDateStruct":159,"startDateStruct":161,"completionDateStruct":163,"leadSponsor":165,"locationsCount":71},"100617738","smartwatch-accuracy-for-measuring-vitals-and-anxiety-before-disc-surgery-100617738","NCT07322523","Smartwatch Accuracy for Measuring Vitals and Anxiety Before Disc Surgery","Validation of Smartwatch Technology for Preoperative Monitoring of Sleep Quality, Anxiety, and Vital Signs in Patients Undergoing Disc Herniation Surgery","Inclusion Criteria:\n\n* 22 years and older\n* Currently receiving preoperative care\u002Fassessment for disc herniation surgery.\n* No history of any cardiovascular disease other than controlled hypertension.\n* Willingness to wear the smartwatch for a minimum of 8 consecutive hours during the night before surgery.\n* Ability to follow all instructions related to the smartwatch operation and data collection independently.\n* No known allergy to nickel.\n\nExclusion Criteria:\n\n* Patients who are currently receiving prescribed medication specifically for sleep in the clinical setting.\n* Refusal or unwillingness to participate in the study.\n* The participant fails to wear the smartwatch correctly or appropriately as per study instructions, leading to incomplete or unreliable data collection.","22 Years",{"count":21,"type":22},"3 Months","This study aims to verify the accuracy of blood pressure, heart rate, blood oxygen saturation, anxiety level, and sleep cycle data measurements obtained from Samsung smartwatches compared to the currently accepted method used in patients with disc herniation undergoing the preoperative period.",[140,141,142,143,144,145,146,147,27,148],"Disc Herniations","Disc Herniation, Lumbar","Cervical Disc Herniation","Preoperative Anxiety Score","Sleep Quality","Preoperative Care","Vital Signs Monitoring","Smart Watch","Surgical Nursing",[150,151,152,153,154,155,156,157],"Disc herniations","wearable devices","smart watch","vital signs monitoring","sleep quality","anxiety","surgical nursing,","preoperative","2025-12-22",{"date":160,"type":36},"2026-01-07",{"date":162,"type":36},"2025-11-01",{"date":164,"type":22},"2026-03-30",{"name":166,"class":43},"Halil Kalaycı",{"id":168,"slug":169,"hasResults":11,"nctId":170,"briefTitle":171,"officialTitle":172,"acronym":173,"eligibilityCriteria":174,"healthyVolunteers":11,"sex":17,"minAge":175,"maxAge":18,"enrollmentInfo":176,"targetDuration":178,"studyType":23,"phases":4,"briefSummary":179,"conditions":180,"keywords":184,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":188,"lastUpdatePostDateStruct":189,"startDateStruct":191,"completionDateStruct":193,"leadSponsor":195,"locationsCount":71},"100595326","wearable-technology-and-machine-learning-for-early-detection-and-risk-assessment-of-unacceptable-toxicities-in-a-paediatric-oncology-cohort-100595326","NCT07030998","Wearable Technology and Machine Learning for Early Detection and Risk Assessment of Unacceptable Toxicities in a Paediatric Oncology Cohort","WEARABLES: Wearable Technology and Machine Learning for Early Detection and Risk Assessment of Unacceptable Toxicities in a Paediatric Oncology Cohort","WEARABLES","Inclusion Criteria:\n\n* Paediatric, adolescent or young adult diagnosis of cancer AND receiving therapy placing them at risk of infection\n* Receiving cancer treatment at The Royal Children's Hospital\n* Patients aged 5-18 years at time of the eligibility screening\n* If aged \\\u003C 16 years, parent or guardian able to provide consent\n* iPhone 8 or later (iOS must be up to date\u002Fupdated at time of enrolment)\n* At least 10MB of iPhone storage for WEARABLES app and data collection.\n* Willing and able to wear a wearable device for a period of 4 weeks (during waking hours).\n* Consent to data being shared to the WEARABLES app (owned by the research team).\n\nExclusion Criteria:\n\n* \\\u003C5 years of age.\n* \\\u003C16 years of age without guardian or parent consent.\n* Aged 16-18 and unable to provide consent.\n* Participant did not consent to wearing Apple Watch for a period of 4 weeks.","5 Years",{"count":177,"type":22},150,"4 Weeks","Data collection study to establish a predictive model of infection observed during childhood cancer therapy using data captured by wearable technology.",[181,182,183,27],"Cancer","Infection","Digital Health",[181,185,182,186,187],"Paediatric","Treatment Toxicity","Wearable Device","2025-11-14",{"date":190,"type":36},"2025-11-17",{"date":192,"type":36},"2025-10-15",{"date":194,"type":22},"2027-12",{"name":196,"class":43},"Murdoch Childrens Research Institute"]